Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-073456
Filing Date
2025-04-04
Accepted
2025-04-04 16:23:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d885326ddefa14a.htm DEFA14A 27391
2 GRAPHIC g885326dsp2aaa.jpg GRAPHIC 95641
3 GRAPHIC g885326dsp2aaaaa.jpg GRAPHIC 120597
4 GRAPHIC g885326dsp3.jpg GRAPHIC 1493
  Complete submission text file 0001193125-25-073456.txt   328629
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14656 | Film No.: 25815068
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)